ASX ANNOUNCEMENT Brisbane, 1st May, 2017 ADMEDUS HSV-2 PHASE IIa RESULTS WEBINAR • Admedus investor webinar Thursday, 4 May 2017 • 9am AEST Sydney/Melbourne/Brisbane time; 7am AWST Perth time Admedus Limited (ASX:AHZ) today announced that it will hold an investor webinar on Thursday, 4 May 2017 to present the results of the HSV-2 Phase IIa program and provide a business overview on the rest of its immunotherapies programs including the HPV treatment program and its work in the area of RNA vaccines. The webinar details Date: 4 May, 2017 Time: 9am Australian Eastern Standard Time (AEST); 7am Australian Western Standard Time (ASWT) Please register to attend the webinar at: https://attendee.gotowebinar.com/register/2780413500734718467 Follow us: Twitter: @Admedus Facebook: www.facebook.com/pages/Admedus Website: www.admedus.com
- Forums
- ASX - By Stock
- Ann: HSV-2 Phase IIa Results Investor Webinar
ASX ANNOUNCEMENT Brisbane, 1st May, 2017 ADMEDUS HSV-2 PHASE IIa...
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $323.4M |
Open | High | Low | Value | Volume |
$15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $15.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.30 | 276 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 15.200 |
1 | 39 | 15.040 |
1 | 1000 | 15.000 |
1 | 756 | 14.950 |
1 | 300 | 14.900 |
Price($) | Vol. | No. |
---|---|---|
15.300 | 276 | 1 |
15.700 | 277 | 1 |
15.880 | 250 | 1 |
16.000 | 100 | 1 |
16.030 | 999 | 1 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online